Clinical Trial Update: An Exploratory Study of Cluster of Differentiation 38 (CD38) Monoclonal Antibody Combined Corticosteroid in Acquired Hemophilia A [Phase 4]

View source ↗

Summary

A Phase 4 exploratory clinical trial evaluating a CD38 monoclonal antibody plus corticosteroid for acquired hemophilia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Hemophilia

Drugs mentioned

• CD38 monoclonal antibody (anti-CD38 monoclonal antibody)
• Corticosteroid (corticosteroid)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Acquired Hemophilia | Phase 4 | Status: RECRUITING